1.0Clinical Pharmacology of Miamihttps://cpmiclinical.com/es/Dylan Bahehttps://cpmiclinical.com/es/author/dylanb/rich600338<blockquote class="wp-embedded-content" data-secret="WZZiZ5pBM1"><a href="https://cpmiclinical.com/es/understanding-liver-impairment-clinical-trials/">Ensayos clínicos sobre deterioro hepático: cómo la investigación impulsa las opciones de tratamiento</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cpmiclinical.com/es/understanding-liver-impairment-clinical-trials/embed/#?secret=WZZiZ5pBM1" width="600" height="338" title="“Comprendiendo los ensayos clínicos sobre insuficiencia hepática: cómo la investigación está impulsando las opciones de tratamiento” — Farmacología Clínica de Miami" data-secret="WZZiZ5pBM1" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://cpmiclinical.com/wp-includes/js/wp-embed.min.js </script>https://cpmiclinical.com/wp-content/uploads/2025/04/Graphics_BMR-copy-4-1-scaled.jpg25601344Liver diseases, including conditions like Metabolic Associated Steatotic Hepatitis (MASH) and cirrhosis, are serious and often progressive disorders that can dramatically impact a person's health and quality of life. However, significant progress is being made in the treatment of these conditions, thanks to clinical trials that are working to develop more effective therapies. By testing new treatments, exploring the mechanisms behind liver disease, and advancing our understanding of how the liver functions, clinical trials are at the forefront of improving outcomes for those affected by liver impairment.